Pricing: View pricing and purchase directly through the Prestige App
Our medically supervised weight loss therapies contain the same active ingredients, such as semaglutide, that are found in FDA-approved, brand-name medications
Independent replication by unaffiliated laboratories is limited
Porphyria: The use of diclofenac and anti-inflammatory steroids in patients with hepatic porphyria should be avoided
Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
Very happy with the kit, the results, everything all around